ENTA Stock Price - Enanta Pharmaceuticals, Inc. logo

ENTA Stock Price

Enanta Pharmaceuticals, Inc.

$8.23
-$0.46(-5.29%)
36
Overall
60
Value
18
Tech
31
Quality
How is this score calculated?
Market Cap
$239.70M
Volume
811.55K
52W Range
$10.05 - $17.15
Target Price
$19.83

ENTA stock price is $8.23 (-5.29% on the day), giving Enanta Pharmaceuticals, Inc. a market cap of $239.70M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

ENTA Stock Overview

Price
$8.23
Previous close
$8.69
Open
$8.47
Market cap
$239.70M
52-week range
$10.05 - $17.15
1-year price target
$19.83
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
36

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

ABCD
1SymbolPriceChangeVol
2ENTA$8.23-5.3%811.55K
3
4
5
6

Get Enanta Pharmaceuticals, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.